UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
Report for the Calendar Year or Quarter Ended:
09-30-2023
Check here if Amendment: ☐ Amendment Number:
This Amendment (Check only one.):☐ is a restatement.
☐ adds new holdings entries.

Institutional Investment Manager Filing this Report:

Name:
BML Capital Management, LLC
Address:
65 E CEDAR - SUITE 2
ZIONSVILLE, IN 46077
Form 13F File Number:
028-22948

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.


Person Signing this Report on Behalf of Reporting Manager:
Name:
Aryn Sands
Title:
Agent
Phone:
844-844-3453


Signature, Place, and Date of Signing:

Aryn Sands
                         [Signature]
Reno, NEVADA
                 [City, State]
10-23-2023
                           [Date]
                          

Report Type (Check only one.):

☒ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 

☐ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 

☐ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)


Form 13F Summary Page

Report Summary:

Number of Other Included Managers:
0
Form 13F Information table Entry Total:
26
Form 13F Information table Value Total:
108900443
          (thousands)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

  
NONE


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
ARCA BIOPHARMA INCCOM00211Y5061,420,929706,930SHSOLE 0 0 706,930
ADVERUM BIOTECHNOLOGIES INCCOM00773U1085,872,5003,915,000SHSOLE 0 0 3,915,000
ASTROTECH CORPCOM0464843092,226,141220,410SHSOLE 0 0 220,410
ATEA PHARMACEUTICALS INCCOM04683R10614,400,0004,800,000SHSOLE 0 0 4,800,000
ATHIRA PHARMA INCCOM04746L1043,442,8111,704,362SHSOLE 0 0 1,704,362
AVROBIO INCCOM05455M1006,162,5064,001,627SHSOLE 0 0 4,001,627
LISATA THERAPEUTICS INCCOM128058302521,815243,839SHSOLE 0 0 243,839
CYTEIR THERAPEUTICS INCCOM23284P1039,230,0233,250,008SHSOLE 0 0 3,250,008
ELIEM THERAPEUTICS INCCOM28658R1065,097,6321,938,263SHSOLE 0 0 1,938,263
ENLIVEN THERAPEUTICS INCCOM29337E102683,00050,000SHSOLE 0 0 50,000
FORTE BIOSCIENCES INCCOM34962G1091,166,2471,761,702SHSOLE 0 0 1,761,702
CALCIMEDICA INCCOM NEW38942Q202236,11388,781SHSOLE 0 0 88,781
INVESCO QQQ TRUNIT SER 146090E103443,880108SHPutSOLE 0 0 108
ISHARES TR0-3 MNTH TREASRY46436E71827,180,900270,000SHSOLE 0 0 270,000
MILESTONE PHARMACEUTICALS INCOM59935V107844,750272,500SHSOLE 0 0 272,500
NEOLEUKIN THERAPEUTICS INCCOM NEW64049K203389,72398,664SHSOLE 0 0 98,664
NEXTCURE INCCOM65343E108395,340306,465SHSOLE 0 0 306,465
ORAMED PHARMACEUTICALS INCCOM NEW68403P2032,039,172781,292SHSOLE 0 0 781,292
PASSAGE BIO INCCOM7027121001,354,6692,058,767SHSOLE 0 0 2,058,767
RAIN ONCOLOGY INCCOM75082Q10562,84872,926SHSOLE 0 0 72,926
RETRACTABLE TECHNOLOGIES INCCOM76129W105594,951499,959SHSOLE 0 0 499,959
SPDR SER TRBLOOMBERG 1-3 MO78468R66318,364,000200,000SHSOLE 0 0 200,000
SURROZEN INCCOM86889P10943,74389,271SHSOLE 0 0 89,271
TALARIS THERAPEUTICS INCCOM87410C1045,620,0002,000,000SHSOLE 0 0 2,000,000
VERRICA PHARMACEUTICALS INCCOM92511W108582,750150,000SHSOLE 0 0 150,000
VISTAGEN THERAPEUTICS INCCOM92840H400524,000100,000SHSOLE 0 0 100,000